These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

790 related items for PubMed ID: 17550976

  • 21. The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.
    Horsch K, Schaller MD, Hynes NE.
    Mol Endocrinol; 2001 Dec; 15(12):2182-96. PubMed ID: 11731619
    [Abstract] [Full Text] [Related]

  • 22. Impact of heat stress on prolactin-mediated ovarian JAK-STAT signaling in postpubertal gilts.
    Roach CM, Bidne KL, Romoser MR, Ross JW, Baumgard LH, Keating AF.
    J Anim Sci; 2022 Jul 01; 100(7):. PubMed ID: 35772766
    [Abstract] [Full Text] [Related]

  • 23. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
    Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM.
    Endocrinology; 1999 Nov 01; 140(11):5087-94. PubMed ID: 10537136
    [Abstract] [Full Text] [Related]

  • 24. Interactions among Janus kinases and the prolactin (PRL) receptor in the regulation of a PRL response element.
    Gao J, Hughes JP, Auperin B, Buteau H, Edery M, Zhuang H, Wojchowski DM, Horseman ND.
    Mol Endocrinol; 1996 Jul 01; 10(7):847-56. PubMed ID: 8813725
    [Abstract] [Full Text] [Related]

  • 25. JAK/STAT/SOCS-signaling pathway and colon and rectal cancer.
    Slattery ML, Lundgreen A, Kadlubar SA, Bondurant KL, Wolff RK.
    Mol Carcinog; 2013 Feb 01; 52(2):155-66. PubMed ID: 22121102
    [Abstract] [Full Text] [Related]

  • 26. Janus kinase-signal transducer and activator of transcription mediates phosphatidic acid-induced interleukin (IL)-1beta and IL-6 production.
    Lee C, Lim HK, Sakong J, Lee YS, Kim JR, Baek SH.
    Mol Pharmacol; 2006 Mar 01; 69(3):1041-7. PubMed ID: 16354768
    [Abstract] [Full Text] [Related]

  • 27. Prolactin-stimulated activation of ERK1/2 mitogen-activated protein kinases is controlled by PI3-kinase/Rac/PAK signaling pathway in breast cancer cells.
    Aksamitiene E, Achanta S, Kolch W, Kholodenko BN, Hoek JB, Kiyatkin A.
    Cell Signal; 2011 Nov 01; 23(11):1794-805. PubMed ID: 21726627
    [Abstract] [Full Text] [Related]

  • 28. Src mediates prolactin-dependent proliferation of T47D and MCF7 cells via the activation of focal adhesion kinase/Erk1/2 and phosphatidylinositol 3-kinase pathways.
    Acosta JJ, Muñoz RM, González L, Subtil-Rodríguez A, Dominguez-Caceres MA, García-Martínez JM, Calcabrini A, Lazaro-Trueba I, Martín-Pérez J.
    Mol Endocrinol; 2003 Nov 01; 17(11):2268-82. PubMed ID: 12907754
    [Abstract] [Full Text] [Related]

  • 29. Platelet-derived growth factor (PDGF)-induced activation of signal transducer and activator of transcription (Stat) 5 is mediated by PDGF beta-receptor and is not dependent on c-src, fyn, jak1 or jak2 kinases.
    Paukku K, Valgeirsdóttir S, Saharinen P, Bergman M, Heldin CH, Silvennoinen O.
    Biochem J; 2000 Feb 01; 345 Pt 3(Pt 3):759-66. PubMed ID: 10642538
    [Abstract] [Full Text] [Related]

  • 30. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
    Friedrichsen BN, Galsgaard ED, Nielsen JH, Møldrup A.
    Mol Endocrinol; 2001 Jan 01; 15(1):136-48. PubMed ID: 11145745
    [Abstract] [Full Text] [Related]

  • 31. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
    Fang F, Rycyzyn MA, Clevenger CV.
    Endocrinology; 2009 Apr 01; 150(4):1597-606. PubMed ID: 19036881
    [Abstract] [Full Text] [Related]

  • 32. The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.
    Sakamoto K, Creamer BA, Triplett AA, Wagner KU.
    Mol Endocrinol; 2007 Aug 01; 21(8):1877-92. PubMed ID: 17519353
    [Abstract] [Full Text] [Related]

  • 33. Sesquiterpene dimmer (DSF-27) inhibits the release of neuroinflammatory mediators from microglia by targeting spleen tyrosine kinase (Syk) and Janus kinase 2 (Jak2): Two major non-receptor tyrosine signaling proteins involved in inflammatory events.
    Zeng KW, Wang S, Dong X, Jiang Y, Jin HW, Tu PF.
    Toxicol Appl Pharmacol; 2014 Mar 15; 275(3):244-56. PubMed ID: 24486434
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P, Kaushik G, Ghosh C, Standing D, Ali Sayed AA, Choudhury S, Subramaniam D, Manzardo A, Banerjee T, Santra S, Ramamoorthy P, Butler M, Padhye SB, Baranda J, Kasi A, Sun W, Tawfik O, Coppola D, Malafa M, Umar S, Soares MJ, Saha S, Weir SJ, Dhar A, Jensen RA, Thomas SM, Anant S.
    Gastroenterology; 2020 Apr 15; 158(5):1433-1449.e27. PubMed ID: 31786131
    [Abstract] [Full Text] [Related]

  • 36. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL.
    J Histochem Cytochem; 2002 Mar 15; 50(3):365-83. PubMed ID: 11850439
    [Abstract] [Full Text] [Related]

  • 37. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM.
    Biochemistry; 2003 Jun 24; 42(24):7561-70. PubMed ID: 12809512
    [Abstract] [Full Text] [Related]

  • 38. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A, Barkai U, Tessier C, Cohen H, Gibori G.
    Endocrinology; 2001 Mar 24; 142(3):1242-50. PubMed ID: 11181541
    [Abstract] [Full Text] [Related]

  • 39. Prolactin enhances interferon-gamma-induced production of CXC ligand 9 (CXCL9), CXCL10, and CXCL11 in human keratinocytes.
    Kanda N, Watanabe S.
    Endocrinology; 2007 May 24; 148(5):2317-25. PubMed ID: 17255201
    [Abstract] [Full Text] [Related]

  • 40. Targeting the Janus-activated kinase-2-STAT3 signalling pathway in pancreatic cancer using the HSP90 inhibitor ganetespib.
    Nagaraju GP, Mezina A, Shaib WL, Landry J, El-Rayes BF.
    Eur J Cancer; 2016 Jan 24; 52():109-19. PubMed ID: 26682870
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.